Filing Details

Accession Number:
0001209191-20-057806
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-11-12 06:00:42
Reporting Period:
2020-11-10
Accepted Time:
2020-11-12 06:00:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1610618 Cidara Therapeutics Inc. CDTX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1463151 E. James Levine C/O Cidara Therapeutics, Inc.
6310 Nancy Ridge Dr #101
San Diego CA 92121
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-11-10 50,000 $2.01 50,000 No 4 P Indirect by spouse's IRA
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect by spouse's IRA
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 65,834 Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.97to $2.05, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities andExchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range setforth above.
  2. Includes 3,943 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on May 20, 2020.